Fei Cao
Chief Executive Officer en HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. .
Fortuna: 288 223 $ al 31/03/2024
Perfil
Fei Cao has held positions at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Jumpcan Pharmaceutical Co. Ltd.
His current job titles include Vice Chairman & General Manager at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Director at Jumpcan Pharmaceutical Co. Ltd.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
13/09/2022 | 1 961 500 ( 0.15% ) | 288 223 $ | 31/03/2024 |
Cargos activos de Fei Cao
Empresas | Cargo | Inicio |
---|---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 20/12/2019 |
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |
- Bolsa de valores
- Insiders
- Fei Cao